BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28394798)

  • 1. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
    Lezcano C; Ho J; Seethala RR
    Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of SOX10 in Salivary Gland Oncocytic Neoplasms: A Review and a Comparative Analysis with Other Immunohistochemical Markers.
    Schmitt AC; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(5):384-90. PubMed ID: 26619208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of DOG1 immunohistochemistry in dermatopathology.
    Goto K
    J Cutan Pathol; 2016 Nov; 43(11):974-983. PubMed ID: 27506854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
    Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
    Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
    Thamboo TP; Tan LH; Tan SY
    J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the diagnosis of cutaneous adnexal tumours.
    Danialan R; Mutyambizi K; Aung P; Prieto VG; Ivan D
    J Clin Pathol; 2015 Dec; 68(12):992-1002. PubMed ID: 26602416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
    Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
    J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYB, CD117 and SOX-10 expression in cutaneous adnexal tumors.
    Evangelista MT; North JP
    J Cutan Pathol; 2017 May; 44(5):444-450. PubMed ID: 28098399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin.
    Ivan D; Hafeez Diwan A; Prieto VG
    Mod Pathol; 2005 Jan; 18(1):137-42. PubMed ID: 15389254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
    Pardal J; Sundram U; Selim MA; Hoang MP
    Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity for Sox10 in Basaloid Neoplasms of The Skin.
    Bush JW; Gru AA; Wick MR
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):114-118. PubMed ID: 30531326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma.
    Plumb SJ; Argenyi ZB; Stone MS; De Young BR
    Am J Dermatopathol; 2004 Dec; 26(6):447-51. PubMed ID: 15618924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers.
    Khurram SA; Speight PM
    Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples.
    Jansen K; Farahi N; Büscheck F; Lennartz M; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Clauditz T; Bernreuther C; Dum D; Krech T; Marx A; Steurer S
    Pathol Res Pract; 2021 Dec; 228():153663. PubMed ID: 34717148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
    Plaza JA; Ortega PF; Stockman DL; Suster S
    J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
    Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
    J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
    González-Guerra E; Kutzner H; Rutten A; Requena L
    Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors.
    Ibrahim TR; Ahmed MM; Hegazy AA
    Turk Patoloji Derg; 2020; 36(3):227-236. PubMed ID: 32692399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.